3/11/2024
06:30 am
kalv
Q3/2023 1/31/2024 EPS -0.840 ZacksConsensus -0.750 ActVsEst (0.090) - Miss
Medium
Report
kalvista pharmaceuticals, inc.
7/7/2023
06:30 am
kalv
Q4/2022 4/30/2023 EPS -0.770 ZacksConsensus -0.920 ActVsEst 0.150 - Beat
High
Report
kalvista pharmaceuticals, inc.